2020 was the seminal year when several biotechnology firms from the psychedelic space IPOed as investments into curing mental illness continued to gain traction among investors.
Psychedelic drugs such asPsilocybin, LSD and Ketamine have long shown great potential in treating severe psychiatric conditions like depression,addiction, post-traumatic stress disorders and other conditions.
We are the perfect destination for Indian and International clients looking for a skilled approach to all their research content without compromising on the superiority and exclusivity of the subject.
Sign- up to receive the latest inputs and newsletters on the financial markets
© Copyright 2017 Take Stock Research. All Rights Reserved.